Ms Megan Johnson > Dechert LLP > Washington DC, United States > Lawyer Profile
Dechert LLP Offices
1900 K STREET, NW
WASHINGTON DC 20006
DISTRICT OF COLUMBIA
United States
- Firm Profile
- Go to...
Ms Megan Johnson
Work Department
Financial Services and Investment Management
Position
Partner
Career
Megan C. Johnson is a partner in the financial services group. She regularly advises U.S registered investment companies, as well as their investment advisers and other service providers, on a wide variety of regulatory, compliance and corporate matters, including the development, organization and registration of new funds, regulatory and compliance matters relating to existing funds, registration and proxy statements, fund reorganizations, and affiliated transaction matters under the Investment Company Act of 1940.
Ms. Johnson has particular experience advising mutual funds, exchange-traded funds and their boards of directors on a full range of issues under the Investment Company Act of 1940, including affiliation issues, legal issues related to advisory fees and distribution arrangements, fund structuring and reorganizations, ongoing compliance and regulatory matters, disclosure, and fiduciary oversight matters.
Prior to rejoining Dechert in March 2006, Ms. Johnson was employed as counsel at a large investment management firm.
Education
- Northwestern University, B.A., 1997
- Case Western Reserve University School of Law, J.D., 2003, magna cum laude, Order of the Coif
Lawyer Rankings
United States > Investment fund formation and management > Mutual/registered/exchange-traded funds
(Next Generation Partners)Dechert LLP has a longstanding record in the mutual funds space, with funds, fund advisors and boards of directors, broker dealers, insurance companies and banks turning to the financial services team for comprehensive service. The team advises open- and closed-end funds, exchange-traded funds, interval funds and on insurance products, covering a plethora of issues, including but not limited to regulatory and compliance matters, related litigation, regulatory investigation and the formation and management of these funds. Experienced partner Christopher Harvey leads the team out of the Boston office, and is supported by John O’Hanlon, who covers corporate, regulatory, compliance and enforcement matters for funds clients, and Stephanie Capistron, who among other capabilities advises mutual fund sponsors on launching ETFs in the same location. In New York Allison Fumai has extensive experience with exchange traded funds, but frequently works with mutual funds and closed-end funds as well, while in San Francisco Mark Perlow advises fund sponsors and investors on the related ESG regulation. Douglas Dick and Megan Johnson are based in Washington DC, with the latter advising mutual funds and EFTs on staying compliant with the Investment Company Act of 1940. The team underwent some changes in 2023 with Michael McGrath joining the firm from K&L Gates in March, and Kaitlin McGrath receiving being promoted to partner in January of the same year, both located in Boston and part of the financial Services and investment management team.
Lawyer Rankings
- Mutual/registered/exchange-traded funds United States > Investment fund formation and management
- Next Generation Partners United States > Investment fund formation and management > Mutual/registered/exchange-traded funds
Top Tier Firm Rankings
- Environment > Environment: transactional
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Antitrust > Civil litigation/class actions: defense
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate finance
- Finance > Structured finance: securitization
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > E-discovery
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Finance > Restructuring (including bankruptcy): corporate
- Tax > US taxes: non-contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- International trade > Customs, export controls and economic sanctions
- Dispute resolution > International arbitration
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: litigation (full coverage)
- Finance > Capital markets: high-yield debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Investment fund formation and management > Alternative/hedge funds
- Dispute resolution > Financial services litigation